Polycythemia Vera

"Polycythemia Vera" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A myeloproliferative disorder of unknown etiology, characterized by abnormal proliferation of all hematopoietic bone marrow elements and an absolute increase in red cell mass and total blood volume, associated frequently with splenomegaly, leukocytosis, and thrombocythemia. Hematopoiesis is also reactive in extramedullary sites (liver and spleen). In time myelofibrosis occurs.

Descriptor ID	D011087
MeSH Number(s)	C04.588.448.200.500 C15.378.190.250.500 C15.378.190.636.753 C15.378.400.200.500
Concept/Terms	Polycythemia Vera Polycythemia Vera Primary Polycythemia Polycythemia, Primary Polycythemias, Primary Primary Polycythemias Polycythemia Rubra Vera Polycythemia Rubra Veras Vera, Polycythemia Rubra Veras, Polycythemia Rubra Polycythemia Ruba Vera Polycythemia Ruba Veras Ruba Vera, Polycythemia Ruba Veras, Polycythemia Vera, Polycythemia Ruba Veras, Polycythemia Ruba Osler-Vaquez Disease Disease, Osler-Vaquez Osler Vaquez Disease Erythremia Erythremias

Below are MeSH descriptors whose meaning is more general than "Polycythemia Vera".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Hematologic Neoplasms [C04.588.448]
Bone Marrow Neoplasms [C04.588.448.200]
Polycythemia Vera [C04.588.448.200.500]
Hemic and Lymphatic Diseases [C15]
Hematologic Diseases [C15.378]
Bone Marrow Diseases [C15.378.190]
Bone Marrow Neoplasms [C15.378.190.250]
Polycythemia Vera [C15.378.190.250.500]
Myeloproliferative Disorders [C15.378.190.636]
Polycythemia Vera [C15.378.190.636.753]
Hematologic Neoplasms [C15.378.400]
Bone Marrow Neoplasms [C15.378.400.200]
Polycythemia Vera [C15.378.400.200.500]

Below are MeSH descriptors whose meaning is related to "Polycythemia Vera".

Below are MeSH descriptors whose meaning is more specific than "Polycythemia Vera".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Polycythemia Vera" by people in this website by year, and whether "Polycythemia Vera" was a major or minor topic of these publications.

Bar chart showing 23 publications over 15 distinct years, with a maximum of 4 publications in 2006

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	2	0	2
1997	1	0	1
1999	0	1	1
2004	2	0	2
2005	1	0	1
2006	3	1	4
2008	2	0	2
2010	2	0	2
2011	1	0	1
2012	1	0	1
2015	0	1	1
2016	2	0	2
2020	1	0	1
2021	0	1	1
2022	1	0	1

Below are the most recent publications written about "Polycythemia Vera" by people in Profiles.

Zhang Y, Truong B, Fahl SP, Martinez E, Cai KQ, Al-Saleem ED, Gong Y, Liebermann DA, Soboloff J, Dunbrack R, Levine RL, Fletcher S, Kappes D, Sykes SM, Shapiro P, Wiest DL. The ERK2-DBP domain opposes pathogenesis of a mouse JAK2V617F-driven myeloproliferative neoplasm. Blood. 2022 07 28; 140(4):359-373.

View in: PubMed
Peedin AR, Karp JK. How do I?perform therapeutic phlebotomy? Transfusion. 2021 03; 61(3):673-677.

View in: PubMed
Stempel JM, Gopalakrishnan A, Krishnamoorthy P, Lo KB, Mittal V, Moghbeli N, Varadi G, Rangaswami J. Pulmonary Arterial Hypertension in Hospitalized Patients With Polycythemia Vera?(from the National Inpatient Database). Am J Cardiol. 2021 03 15; 143:154-157.

View in: PubMed
Lee J, Axilbund J, Dalton WB, Laheru D, Watkins S, Chu D, Cravero K, Button B, Kyker-Snowman K, Waters I, Gocke CD, Lauring J, Park BH. A Polycythemia Vera JAK2 Mutation Masquerading as a Duodenal Cancer Mutation. J Natl Compr Canc Netw. 2016 12; 14(12):1495-1498.

View in: PubMed
Casu C, Oikonomidou PR, Chen H, Nandi V, Ginzburg Y, Prasad P, Fleming RE, Shah YM, Valore EV, Nemeth E, Ganz T, MacDonald B, Rivella S. Minihepcidin peptides as disease modifiers in mice affected by ?-thalassemia and polycythemia vera. Blood. 2016 07 14; 128(2):265-76.

View in: PubMed
Gross-Davis CA, Heavner K, Frank AL, Newschaffer C, Klotz J, Santella RM, Burstyn I. The role of genotypes that modify the toxicity of chemical mutagens in the risk for myeloproliferative neoplasms. Int J Environ Res Public Health. 2015 Feb 24; 12(3):2465-85.

View in: PubMed
Ballen KK, Woolfrey AE, Zhu X, Ahn KW, Wirk B, Arora M, George B, Savani BN, Bolwell B, Porter DL, Copelan E, Hale G, Schouten HC, Lewis I, Cahn JY, Halter J, Cortes J, Kalaycio ME, Antin J, Aljurf MD, Carabasi MH, Hamadani M, McCarthy P, Pavletic S, Gupta V, Deeg HJ, Maziarz RT, Horowitz MM, Saber W. Allogeneic hematopoietic cell transplantation for advanced polycythemia vera and essential thrombocythemia. Biol Blood Marrow Transplant. 2012 Sep; 18(9):1446-54.

View in: PubMed
Landolfi R, Di Gennaro L, Nicolazzi MA, Giarretta I, Marfisi R, Marchioli R. Polycythemia vera: gender-related phenotypic differences. Intern Emerg Med. 2012 Dec; 7(6):509-15.

View in: PubMed
Seaman V, Dearwent SM, Gable D, Lewis B, Metcalf S, Orloff K, Tierney B, Zhu J, Logue J, Marchetto D, Ostroff S, Hoffman R, Xu M, Carey D, Erlich P, Gerhard G, Roda P, Iannuzzo J, Lewis R, Mellow J, Mulvihill L, Myles Z, Wu M, Frank A, Gross-Davis CA, Klotz J, Lynch A, Weissfeld J, Weinberg R, Cole H. A multidisciplinary investigation of a polycythemia vera cancer cluster of unknown origin. Int J Environ Res Public Health. 2010 03; 7(3):1139-52.

View in: PubMed
Landolfi R, Nicolazzi MA, Porfidia A, Di Gennaro L. Polycythemia vera. Intern Emerg Med. 2010 Oct; 5(5):375-84.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement